Today: 22 July 2026
Browse Category

Earnings 11 December 2025 - 5 January 2026

Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

As of 1:05 p.m. ET in New York on Friday, December 26, 2025, Netflix, Inc. is trading at $94.22, up about 0.6% on the day in a quiet, post-holiday session. The broader tape is mixed: the S&P 500 ETF is fractionally lower while the Nasdaq-100 ETF is roughly flat—typical of thin year-end trading where stock-specific headlines can matter more than macro catalysts.
26 December 2025
···
Philip Morris International (PM) Stock After Hours Today (Dec. 18, 2025): What to Watch Before the Market Opens Friday

Philip Morris International (PM) Stock After Hours Today (Dec. 18, 2025): What to Watch Before the Market Opens Friday

Philip Morris International Inc. ended Thursday’s session lower and was little changed in after-hours trading, even as the broader market rallied on softer-than-expected U.S. inflation data. With Friday’s open set to land on a major derivatives expiration day—and with rate expectations back in focus—investors will be watching whether PM resumes its recent trend or continues to lag the tape.
19 December 2025
·
Space Technology Stocks Today (Dec. 17, 2025): Rocket Lab’s Rapid Space Force Launch, BlackSky’s Gen‑3 Milestone, and Spire Earnings Jolt a Volatile Sector

Space Technology Stocks Today (Dec. 17, 2025): Rocket Lab’s Rapid Space Force Launch, BlackSky’s Gen‑3 Milestone, and Spire Earnings Jolt a Volatile Sector

NEW YORK — As of 6:00 p.m. ET on Wednesday, December 17, 2025, U.S.-listed space technology stocks finished a bruising session largely in the red, pressured by a broader tech-led pullback that hit higher‑beta growth names. The S&P 500 fell 1.2% to 6,721.43 and the Nasdaq slid 1.8% to 22,693.32, extending Wall Street’s multi-day decline amid renewed investor anxiety around big-ticket technology spending and funding for data-center buildouts. AP News+1
18 December 2025
Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Wall Street heads into the week of Dec. 15, 2025 with U.S. healthcare and pharma mega-caps back in the spotlight—pulled by three powerful forces that all intensified in the last seven days: the obesity-drug arms race, Washington’s policy crosscurrents around insurance subsidies and PBM transparency, and a faster-moving FDA that is simultaneously accelerating reviews and reopening safety scrutiny in sensitive pediatric categories. Reuters+3Reuters+3Reuters+3
14 December 2025
······
1 … 9 10 11 12 13 … 16
Go toTop